Zhou H[au] - Search Results

Year	Number of Results
1979	1
1980	3
1981	3
1982	6
1983	3
1984	5
1985	9
1986	15
1987	14
1988	13
1989	24
1990	31
1991	25
1992	30
1993	40
1994	34
1995	66
1996	76
1997	107
1998	108
1999	122
2000	139
2001	180
2002	197
2003	249
2004	327
2005	425
2006	486
2007	571
2008	628
2009	756
2010	826
2011	948
2012	1062
2013	1256
2014	1417
2015	1586
2016	1717
2017	1877
2018	2120
2019	2428
2020	2983
2021	1623

1

miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1.

Xiao P, Liu W, Zhou H. Xiao P, et al. Among authors: zhou h. Oncol Lett. 2021 Jul;22(1):545. doi: 10.3892/ol.2021.12806. Epub 2021 May 24. Oncol Lett. 2021. PMID: 34093767 Free PMC article.

2

Progression of Metastasis through Lymphatic System.

Zhou H, Lei PJ, Padera TP. Zhou H, et al. Cells. 2021 Mar 12;10(3):627. doi: 10.3390/cells10030627. Cells. 2021. PMID: 33808959 Free PMC article. Review.

3

Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis.

Yao MQ, Zheng QX, Xu J, Deng JW, Ge TT, Zhou HB, Wu FT, Gu XY, Yang Q, Ren YL, Wang G, Chen Z. Yao MQ, et al. Among authors: zhou hb. J Zhejiang Univ Sci B. 2020 Dec.;21(12):940-947. doi: 10.1631/jzus.B2000304. J Zhejiang Univ Sci B. 2020. PMID: 33843159 Free PMC article.

4

Eshelby untwisting.

Zhong X , Zhou H , Li C , Shtukenberg AG , Ward MD , Kahr B . Zhong X , et al. Among authors: zhou h. Chem Commun (Camb). 2021 Jun 7;57(45):5538-5541. doi: 10.1039/d1cc01431e. Epub 2021 May 7. Chem Commun (Camb). 2021. PMID: 33960341

5

Ferritinophagy and ferroptosis in the management of metabolic diseases.

Ajoolabady A, Aslkhodapasandhokmabad H, Libby P, Tuomilehto J, Lip GYH, Penninger JM, Richardson DR, Tang D, Zhou H, Wang S, Klionsky DJ, Kroemer G, Ren J. Ajoolabady A, et al. Among authors: zhou h. Trends Endocrinol Metab. 2021 Jul;32(7):444-462. doi: 10.1016/j.tem.2021.04.010. Epub 2021 May 15. Trends Endocrinol Metab. 2021. PMID: 34006412 Review.

6

Exosomes in osteosarcoma research and preclinical practice.

Zhang XB, Zhang RH, Su X, Qi J, Hu YC, Shi JT, Zhang K, Wang KP, Zhou HY. Zhang XB, et al. Among authors: zhou hy. Am J Transl Res. 2021 Mar 15;13(3):882-897. eCollection 2021. Am J Transl Res. 2021. PMID: 33841628 Free PMC article. Review.

7

Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses: A Retrospective Analysis.

Vieira MC, Li Y, Meng X, Zhou H, Piao OW, Kutz C, Conway D. Vieira MC, et al. Among authors: zhou h. Int J MS Care. 2021 Mar-Apr;23(2):73-78. doi: 10.7224/1537-2073.2019-050. Epub 2020 Apr 28. Int J MS Care. 2021. PMID: 33880083 Free PMC article.

8

A review of pharmacological and pharmacokinetic properties of Forsythiaside A.

Gong L, Wang C, Zhou H, Ma C, Zhang Y, Peng C, Li Y. Gong L, et al. Among authors: zhou h. Pharmacol Res. 2021 May 23;169:105690. doi: 10.1016/j.phrs.2021.105690. Online ahead of print. Pharmacol Res. 2021. PMID: 34029711 Review.

9

Towards a Framework for Better Understanding of Quiescent Cancer Cells.

Nik Nabil WN, Xi Z, Song Z, Jin L, Zhang XD, Zhou H, De Souza P, Dong Q, Xu H. Nik Nabil WN, et al. Among authors: zhou h. Cells. 2021 Mar 5;10(3):562. doi: 10.3390/cells10030562. Cells. 2021. PMID: 33807533 Free PMC article. Review.

10

Long non-coding RNA TUG1 knockdown hinders the tumorigenesis of multiple myeloma by regulating the microRNA-34a-5p/NOTCH1 signaling pathway.

Zhang Y, Zhao D, Li S, Xiao M, Zhou H, Yang S, Hao Y, Dong S. Zhang Y, et al. Among authors: zhou h. Open Life Sci. 2020 Jun 9;15(1):284-295. doi: 10.1515/biol-2020-0025. eCollection 2020. Open Life Sci. 2020. PMID: 33817217 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results